Analyst Ratings (USA)
Aardvark Therapeutics was rated Buy by HC Wainwright, with a target price of $40.00.
AbbVie received a Buy rating from Morgan Stanley, with a price target of $250.00.
Aemetis had its target raised by UBS Group, reaffirming a Buy rating and lifting the price from $2.20 to $3.00.
AeroVironment was initiated with a Buy rating by The Goldman Sachs Group, targeting $301.00.
Affirm had its target raised by Barclays and maintained an Overweight rating, with the price increased from $67.00 to $80.00.
Agnico Eagle Mines received an Outperform initiation from Raymond James Financial, with a target price of $130.00.
Agree Realty was reiterated as Market Perform by JMP Securities.
Air Products and Chemicals was reiterated with a Buy rating by Citigroup, increasing the target from $310.00 to $320.00.
Alnylam Pharmaceuticals had its target raised by Wells Fargo & Company, maintaining an Equal Weight rating, and the price increased from $287.00 to $333.00.
American Healthcare REIT was initiated at Sector Outperform by Scotiabank, with a target of $42.00.
Amgen received a Buy rating from TD Cowen, with a price target of $389.00.
Amgen was rated Hold by Morgan Stanley, with a target of $330.00.
Amplify Energy was initiated with a Buy rating by Alliance Global Partners, with a price target of $6.00.
Anglogold Ashanti PLC received a Buy rating from Roth MKM, with a target price of $54.00.
Antero Resources was rated Hold by Citi, with a target of $45.00.
Aramark was maintained at Equal Weight by Morgan Stanley, with a price target increase from $42.00 to $44.00.
Argenx Se also received a Buy rating from Wells Fargo, targeting $741.00.
Argenx Se was rated Buy by Citi, with a target price of $803.00.
ARM had its target raised by Guggenheim, keeping a Buy rating and lifting the price from $147.00 to $187.00.
Aurinia Pharmaceuticals was rated Buy by both Leerink Partners and TD Cowen, with targets of $10.00 and $11.00, respectively.
Aytu BioPharma was given a Buy initiation by Ascendiant Capital Markets, with a target price of $12.00.
B2Gold was initiated with an Outperform rating by Raymond James Financial, targeting $4.50.
Baker Hughes Company was rated Buy by Wells Fargo, aiming for $50.00.
Beazer Homes USA was initiated as Neutral by B. Riley, with a target of $23.00.
BioCryst Pharmaceuticals had its Outperform rating reiterated by Royal Bank of Canada, with a target of $13.00.
BioCryst received a Buy rating from BofA Securities, with a target of $15.00.
Boeing was rated Buy by Citi, with a price target of $220.00.
Boyd Gaming had its Outperform rating reaffirmed by Raymond James Financial, and its target raised from $81.00 to $85.00.
BridgeBio Pharma had its target raised by Wells Fargo & Company, keeping an Overweight rating and raising the price from $67.00 to $76.00.
BridgeBio Pharma received a Buy rating from Raymond James, with a price target of $57.00.
Brookfield Asset Management was initiated with a Neutral rating by Piper Sandler, targeting $60.00.
CAE was initiated with a Buy rating by The Goldman Sachs Group, with a target of $33.00.
Candel Therapeutics received a Buy initiation from HC Wainwright, targeting $23.00.
Capricor Therapeutics was initiated at Buy by Alliance Global Partners, with a price target of $20.00.
CarMax received a Buy rating from Morgan Stanley, with a price target of $80.00.
Celcuity had its Buy rating reiterated by Needham & Company LLC, with a target of $29.00.
Celcuity received a Buy rating from LifeSci Capital, with a target of $27.00.
Cencora was rated Hold by Jefferies Financial Group, with a raised target of $300.00.
Century Communities was initiated with a Buy rating by B. Riley, targeting $70.00.
Chemed had its Buy rating maintained by Bank of America, though the price target was lowered from $708.00 to $650.00.
Cidara Therapeutics had its Market Outperform rating reiterated by JMP Securities, with a target of $59.00.
Circle Internet Group was rated Buy by Canaccord Genuity Group, with a target price of $247.00.
Circle Internet Group was rated Buy by Citigroup, with a target price of $243.00.
Circle Internet Group was rated Buy by Needham & Company LLC, with a target price of $250.00.
Circle Internet Group was rated Hold by Deutsche Bank Aktiengesellschaft, with a target price of $155.00.
Circle Internet Group was rated Market Perform by Oppenheimer (no price target provided).
Circle Internet Group was rated Neutral by The Goldman Sachs Group, with a target price of $83.00.
Circle Internet Group was rated Outperform by Sanford C. Bernstein, with a target price of $230.00.
Circle Internet Group was rated Overweight by Barclays, with a target price of $215.00.
Circle Internet Group was rated Underweight by JPMorgan Chase & Co., with a target price of $80.00.
Citius Pharmaceuticals was rated Buy by D. Boral Capital, with a target of $6.00.
Clene was rated Buy by D. Boral Capital, with a target price of $23.00.
Cloudastructure received a Buy rating from Maxim Group, targeting $6.00.
Coeur Mining was rated Buy by Roth MKM, with a target price of $12.00.
Cogent Biosciences was rated Neutral by Wedbush, targeting $10.00.
Cohen & Steers was initiated with an Underperform rating by Bank of America, targeting $67.00.
Comfort Systems USA was rated Buy by DA Davidson, and the price target was raised to $630.00.
Concentrix was rated Buy by Canaccord Genuity Group, with a price target of $80.00.
Consolidated Edison was upgraded to Outperform by Mizuho, with a target of $107.00.
CoreCivic received a Buy rating from Texas Capital Securities, targeting $28.00.
CorMedix was downgraded to Hold by D. Boral Capital (no new price target provided).
Crocs was rated Buy by Bank of America, with a reduced target of $135.00.
CVS Health was rated Buy by Jefferies Financial Group, with a new target of $80.00.
Dave was rated Buy by Benchmark, with a raised price target of $320.00.
Dayforce was rated Buy by Needham & Company LLC, targeting $95.00.
Delek US was rated Outperform by Raymond James Financial, with a price target of $23.00.
Dianthus Therapeutics was assigned a Buy rating by LifeSci Capital, with a target of $45.00.
DoorDash was rated Outperform by Oppenheimer, targeting $280.00.
Driven Brands was initiated as Buy by BTIG Research, targeting $22.00.
Duolingo was rated Buy by Evercore ISI, targeting $540.00.
Dutch Bros was initiated as Outperform by CICC Research, targeting $80.00.
eBay was rated Equal Weight by Wells Fargo & Company, with a new target of $66.00.
Edgewise Therapeutics was initiated with a Buy rating by HC Wainwright, with a price target of $42.00.
Emerson Electric Company received a Buy rating from KeyBanc, with a price target of $155.00.
Etsy was rated Underweight by Wells Fargo & Company, with a raised target of $41.00.
Exelixis was rated Buy by HC Wainwright, with a revised target of $53.00.
Expand Energy also received a Buy rating from Mizuho Securities, with a target of $142.00.
Expand Energy received a Buy rating from Citi, targeting $140.00.
Expeditors International of Washington was rated Hold by Truist Financial, with a revised target of $110.00.
Expro Group Holdings received a Buy rating from Wells Fargo, with a target price of $12.00.
Fabrinet was rated Buy by Fox Advisors, with a target of $335.00.
Federal Signal was rated Outperform by Raymond James Financial, with a raised target of $120.00.
First Busey was initiated as Market Perform by Hovde Group, with a target of $25.00.
First Solar received a Buy rating from Wells Fargo, with a price target of $177.00.
Frequency Electronics received a Buy rating from Freedom Capital Markets, targeting $27.00.
Fulcrum Therapeutics was rated Sell by BofA Securities, with a price target of $6.00.
Gain Therapeutics received a Buy rating from BTIG, with a price target of $10.00.
Gain Therapeutics was rated Buy by Roth MKM, with a target price of $7.00.
GeneDx was rated Buy by Guggenheim, with an increased target of $115.00.
Genius Sports was rated Market Outperform by JMP Securities, with a raised price target of $13.00.
Genpact received a Buy rating from Needham & Company LLC, targeting $50.00.
Geo Group was also rated Buy by Texas Capital Securities, with a target of $30.00.
Green Brick Partners was initiated with a Neutral rating by B. Riley, with a target of $62.00.
Grindr received a Market Outperform rating from JMP Securities, with a raised target of $27.00.
Guaranty Bancshares was rated Overweight by Stephens, targeting $47.00.
GXO Logistics was rated Hold by Truist Financial, with a revised target of $48.00.
Hewlett Packard Enterprise received a Buy rating from Bank of America, with a raised target of $23.00.
Hippo Holdings was rated Buy by B.Riley Financial, with a price target of $35.00.
Home Depot received a Buy rating from Citi, aiming for $433.00.
Home Depot received a Buy rating from Wells Fargo, with a price target of $420.00.
Home Depot was rated Outperform by Telsey Advisory Group, targeting $455.00.
Howmet Aerospace was rated Outperform by Royal Bank Of Canada.
Hyatt Hotels also received a Buy rating from BofA Securities, targeting $150.00.
Hyatt Hotels received a Hold rating from Morgan Stanley, targeting $132.00.
Hyatt Hotels was rated Buy by Bernstein, targeting $167.00.
Iamgold was initiated with a Market Perform rating by Raymond James Financial, targeting $8.00.
Indivior was rated Buy by Craig Hallum, with a raised target of $22.00.
Inmune Bio was rated Hold by BTIG, with a price target of $21.00.
Inuvo received a Buy rating from HC Wainwright, with a target raised to $15.00.
Ionis Pharmaceuticals was rated Buy by Barclays, targeting $57.00.
It also received a target raise from Wedbush, maintaining the Outperform rating and increasing the price from $16.00 to $18.00.
J.B. Hunt Transport Services was rated Hold by Truist Financial, with a new price target of $140.00.
Joby Aviation was rated Buy by Canaccord Genuity, with a target of $12.00.
KB Home received a Sell rating from CFRA, with a price target of $49.00.
Kellanova received a Hold rating from TD Cowen, with a price target of $83.50.
Kinross Gold was initiated with a Market Perform rating by Raymond James Financial, targeting $15.00.
KKR & Co. Inc. was initiated with an Overweight rating by Piper Sandler, targeting $150.00.
Kratos Defense & Security Solutions was upgraded to Buy by The Goldman Sachs Group, targeting $52.00.
Krystal Biotech was rated Buy by Clear Street, with a target of $190.00.
Largo received a Buy rating from HC Wainwright, targeting $3.70.
Lear was rated Buy by Citigroup, with a raised target of $136.00.
Leonardo DRS was initiated as Buy by The Goldman Sachs Group, with a target of $49.00.
Linde was upgraded to Buy by Citigroup, with a raised target of $535.00.
M&T Bank was assigned a Buy rating by RBC Capital, with a target of $200.00.
Marathon Petroleum was rated Strong-Buy by Raymond James Financial, with a raised target of $188.00.
MasTec was rated Buy by Roth MKM, with a target of $210.00.
McDonald’s was rated Overweight by KeyCorp, with a revised price target of $325.00.
McEwen Mining received a Buy rating from Roth MKM, with a target of $15.00.
Medical Properties Trust was rated Sector Perform by Royal Bank Of Canada, with a lowered target of $4.50.
Medtronic was upgraded to Peer Perform by Wolfe Research.
Microsoft was reiterated with a Positive rating by UBS Group.
Mister Car Wash was initiated with a Neutral rating by BTIG Research.
Moderna received a Hold rating from Morgan Stanley, targeting $31.00.
Neogen was rated Buy by Guggenheim, with a revised target of $10.00.
New Gold was initiated with a Market Perform rating by Raymond James Financial, targeting $4.00.
Norwegian Cruise Line was rated Neutral by UBS Group, with a reduced price target of $23.00.
NOV also received a Hold rating from Citi, targeting $13.00.
NOV was rated Sell by Wells Fargo, with a target of $10.00.
NU received an Overweight rating from JPMorgan Chase & Co., with a raised target of $16.00.
Nuvalent was rated Buy by Goldman Sachs, targeting $105.00.
Old Dominion Freight Line was rated Buy by Truist Financial, with an updated target of $180.00.
Omeros received a Buy rating from D. Boral Capital, targeting $36.00.
Omnicell was rated Buy by Wells Fargo, with a target of $37.00.
Oracle also received a Buy rating from TD Cowen, targeting $250.00.
Oracle received a Buy rating from Deutsche Bank, with a target of $240.00.
Oracle was upgraded to Buy by Stifel Nicolaus, with a target raised to $250.00.
OS Therapies was rated Buy by D. Boral Capital, with a target of $20.00.
Palomar was rated Outperform by Keefe, Bruyette & Woods, with a revised target of $204.00.
Par Pacific received an Outperform rating from Raymond James Financial, with a raised price target of $30.00.
Parker Hannifin received a Buy rating from BofA Securities, with a target of $715.00.
Pegasystems was rated Buy by Loop Capital, with an increased price target of $60.00.
Planet Labs PBC was initiated with a Neutral rating by The Goldman Sachs Group, targeting $4.60.
PNC Financial received a Buy rating from RBC Capital, aiming for $195.00.
Porch Group received a Buy rating from B.Riley Financial, targeting $15.00.
ProKidney was downgraded to Underperform by Bank of America, with a lowered target of $1.00.
Protagonist Therapeutics received a Buy rating from Citi, with a price target of $72.00.
Qorvo was also rated Hold by Mizuho Securities, targeting $84.00.
Regeneron Pharmaceuticals was downgraded to Hold by Argus.
Robinhood Markets received a Buy rating from KeyBanc, targeting $110.00.
Robinhood Markets was rated Buy by Barclays, targeting $57.00.
Roblox received an Overweight rating from JPMorgan Chase & Co., with a raised target of $120.00.
Rocket Lab was initiated with a Neutral rating by The Goldman Sachs Group, targeting $27.00.
Rocket Pharmaceuticals received a Hold rating from Morgan Stanley, with a target of $7.00.
SailPoint was initiated with an Overweight rating by Cantor Fitzgerald, targeting $29.00.
Schlumberger received an Overweight rating from JPMorgan Chase & Co., with a lowered target of $44.00.
Schlumberger was rated Buy by Wells Fargo, targeting $43.00.
SEI Investments was rated Outperform by Oppenheimer, with a raised target of $96.00.
SharkNinja, Inc. was rated Buy by Jefferies, with a target of $175.00.
Skyworks Solutions received a Hold rating from Mizuho Securities, with a target of $75.00.
Smurfit Westrock received an Overweight rating from Barclays, with a slightly lowered target of $63.00.
Southern Copper received a Hold rating from UBS, with a price target of $105.00.
Starbucks was initiated with an Outperform rating by CICC Research, targeting $100.00.
Stevanato Group was reiterated as Outperform by William Blair.
Strategy was rated Buy by TD Cowen, targeting $590.00.
Summit Therapeutics received a Buy rating from UBS, with a target of $30.00.
Synopsys received a Hold rating from Wells Fargo, with a price target of $520.00.
TD SYNNEX was rated Buy by Loop Capital, with an increased target of $160.00.
Tempus AI was rated Buy by Guggenheim, with a raised target of $75.00.
Tesla received a Buy rating from Deutsche Bank, with a price target of $345.00.
Tesla was rated Buy by Morgan Stanley, with a price target of $410.00.
Tesla was reiterated as Buy by Canaccord Genuity Group, with a target of $303.00.
Transdigm Group was rated Buy by BofA Securities, with a price target of $1,615.00.
Tronox was downgraded to Underperform by BMO Capital Markets, with a reduced target of $3.00.
Tyra Bioscience was rated Buy by Oppenheimer, targeting $30.00.
Unifirst received a target price of $197.00 set by Robert W. Baird.
Unifirst was rated Underweight by Barclays, with a price target of $152.00.
Unifirst was reiterated as Neutral by UBS Group.
United Therapeutics was rated Buy by UBS Group, with a lowered target of $385.00.
US Bancorp was rated Buy by RBC Capital, with a price target of $50.00.
US Gold was assigned a Buy rating by Roth MKM, aiming for $18.00.
Valero Energy was rated Strong-Buy by Raymond James Financial, with a raised target of $155.00.
Vipshop received an Overweight rating from JPMorgan Chase & Co., with a decreased target of $18.00.
Vipshop was given a Hold rating by Citi, with a target of $17.00.
Virgin Galactic was initiated with a Neutral rating by The Goldman Sachs Group, targeting $3.00.
Vor Biopharma was upgraded to Buy by HC Wainwright, targeting $3.00.
Wabash National received a Hold rating from D.A. Davidson, with a target of $9.50.
Walt Disney was upgraded to Buy by Jefferies Financial Group, with a target of $144.00.
Waystar was initiated with an Outperform rating by Mizuho, targeting $48.00.
Whirlpool was upgraded to Buy by Longbow Research, targeting $145.00.
Wingstop was rated Buy by BTIG, with a target of $430.00.
Winnebago Industries was rated Buy by Benchmark, with a reduced price target of $42.00.
XPO was rated Buy by Truist Financial, with a raised target of $135.00.
Zai Lab received an Outperform rating from Leerink Partners, with a revised target of $75.00.
Zai Lab was assigned a Buy rating by Citi, with a target of $66.00.
Zai Lab was rated Buy by Leerink Partners, with a price target of $75.00.
Zynex was reiterated as Buy by HC Wainwright, targeting $8.00.
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.
Great overview of analyst ratings for the week. I noticed Amgen has a split opinion from analysts—Buy from TD Cowen and Hold from Morgan Stanley. It really highlights the differing outlooks on the stock’s potential in the short term.